A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer.
Walker EJ, Simko JP, Nakakura EK, Ko AH.
J Gastrointest Oncol. 2014 Dec;5(6):E88-95. doi: 10.3978/j.issn.2078-6891.2014.051.
Ghouri YA, Mian I, Blechacz B.
J Carcinog. 2015 Feb 23;14:1. doi: 10.4103/1477-3163.151940. eCollection 2015. Review.
Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.
Lunsford KE, Javle M, Heyne K, Shroff RT, Abdel-Wahab R, Gupta N, Mobley CM, Saharia A, Victor DW, Nguyen DT, Graviss EA, Kaseb AO, McFadden RS, Aloia TA, Conrad C, Li XC, Monsour HP, Gaber AO, Vauthey JN, Ghobrial RM; Methodist–MD Anderson Joint Cholangiocarcinoma Collaborative Committee (MMAJCCC).
Lancet Gastroenterol Hepatol. 2018 May;3(5):337-348. doi: 10.1016/S2468-1253(18)30045-1. Epub 2018 Mar 13. Erratum in: Lancet Gastroenterol Hepatol. 2018 Jun;3(6):e3.
Ramírez-Merino N, Aix SP, Cortés-Funes H.
World J Gastrointest Oncol. 2013 Jul 15;5(7):171-6. doi: 10.4251/wjgo.v5.i7.171.
Future directions in the treatment of cholangiocarcinoma.
Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):355-61. doi: 10.1016/j.bpg.2015.02.010. Epub 2015 Feb 19. Review.
A review of the clinical diagnosis and therapy of cholangiocarcinoma.
Yao D, Kunam VK, Li X.
J Int Med Res. 2014 Feb;42(1):3-16. doi: 10.1177/0300060513505488. Epub 2013 Dec 23. Review.
Abdel-Rahman O, Elsayed Z, Elhalawani H.
Cochrane Database Syst Rev. 2018 Apr 6;4:CD011746. doi: 10.1002/14651858.CD011746.pub2. Review.
Czito BG, Hong TJ, Cohen DP, Petros WP, Tyler DS, Pappas TN, Yu D, Lee CG, Lockhart AC, Morse MA, Fernando N, Hurwitz HI.
Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, Zaninotto G, Bonavina L, Peracchia A.
Clin Liver Dis. 2011 Nov;15(4):699-715. doi: 10.1016/j.cld.2011.08.004. Review.
Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary?
Rosen CB, Darwish Murad S, Heimbach JK, Nyberg SL, Nagorney DM, Gores GJ.
J Am Coll Surg. 2012 Jul;215(1):31-8; discussion 38-40. doi: 10.1016/j.jamcollsurg.2012.03.014. Epub 2012 May 22.
Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma.
Strahlenther Onkol. 2010 Dec;186(12):672-80. doi: 10.1007/s00066-010-2161-y. Epub 2010 Nov 30. Review.
Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial.
Stein A, Arnold D, Bridgewater J, Goldstein D, Jensen LH, Klümpen HJ, Lohse AW, Nashan B, Primrose J, Schrum S, Shannon J, Vettorazzi E, Wege H.
BMC Cancer. 2015 Jul 31;15:564. doi: 10.1186/s12885-015-1498-0.
Digestion. 2017;95(3):181-185. doi: 10.1159/000454763. Epub 2017 Mar 14.
What is the role of neoadjuvant chemotherapy, radiation, and adjuvant treatment in resectable esophageal cancer?
Ann Cardiothorac Surg. 2017 Mar;6(2):167-174. doi: 10.21037/acs.2017.03.16.
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
Kuerer HM, Newman LA, Buzdar AU, Dhingra K, Hunt KK, Buchholz TA, Binkley SM, Strom EA, Ames FC, Ross MI, Feig BW, McNeese MD, Hortobagyi GN, Singletary SE.
Cancer J Sci Am. 1998 Jul-Aug;4(4):230-6.